ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc (CYCN)

2.915
-0.035
(-1.19%)
종가: 24 1월 6:00AM
2.915
0.00
( 0.00% )
시간외 거래: 8:00AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
2.915
매수가
2.81
매도가
3.04
거래량
33,895
2.90 일간 변동폭 3.04
1.27 52주 범위 9.4699
market_cap
전일 종가
2.95
개장가
2.99
최근 거래 시간
49
@
2.9
마지막 거래 시간
07:46:43
재정 규모
US$ 99,879
VWAP
2.9467
평균 볼륨(3m)
3,523,625
발행 주식
2,710,096
배당수익률
-
주가수익률
-1.49
주당순이익(EPS)
-1.94
매출
-
순이익
-5.26M

Cyclerion Therapeutics Inc 정보

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Boston, Massachusetts, USA
설립됨
-
Cyclerion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CYCN. The last closing price for Cyclerion Therapeutics was US$2.95. Over the last year, Cyclerion Therapeutics shares have traded in a share price range of US$ 1.27 to US$ 9.4699.

Cyclerion Therapeutics currently has 2,710,096 shares in issue. The market capitalisation of Cyclerion Therapeutics is US$7.99 million. Cyclerion Therapeutics has a price to earnings ratio (PE ratio) of -1.49.

CYCN 최신 뉴스

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth. The...

Regina Graul, Ph.D., Promoted to Chief Executive Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D., has been promoted to Chief Executive Officer...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.125-4.111842105263.043.19922.8295892.92175744CS
4-0.315-9.752321981423.233.66712.8655953.13100029CS
12-0.3444-10.56636190713.25949.46991.2735236255.28997723CS
26-0.485-14.26470588243.49.46991.2715427915.28262503CS
52-0.475-14.011799413.399.46991.277763625.27691138CS
156-20.085-87.32608695652329.81.273555777.37189914CS
260-71.085-96.060810810874179.21.2743619341.70532768CS

CYCN - Frequently Asked Questions (FAQ)

What is the current Cyclerion Therapeutics share price?
The current share price of Cyclerion Therapeutics is US$ 2.915
How many Cyclerion Therapeutics shares are in issue?
Cyclerion Therapeutics has 2,710,096 shares in issue
What is the market cap of Cyclerion Therapeutics?
The market capitalisation of Cyclerion Therapeutics is USD 7.99M
What is the 1 year trading range for Cyclerion Therapeutics share price?
Cyclerion Therapeutics has traded in the range of US$ 1.27 to US$ 9.4699 during the past year
What is the PE ratio of Cyclerion Therapeutics?
The price to earnings ratio of Cyclerion Therapeutics is -1.49
What is the reporting currency for Cyclerion Therapeutics?
Cyclerion Therapeutics reports financial results in USD
What is the latest annual profit for Cyclerion Therapeutics?
The latest annual profit of Cyclerion Therapeutics is USD -5.26M
What is the registered address of Cyclerion Therapeutics?
The registered address for Cyclerion Therapeutics is 155 FEDERAL STREET, SUITE 700, BOSTON, MASSACHUSETTS, 02110
What is the Cyclerion Therapeutics website address?
The website address for Cyclerion Therapeutics is www.cyclerion.com
Which industry sector does Cyclerion Therapeutics operate in?
Cyclerion Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STBXStarBox Group Holdings Ltd
US$ 0.9901
(94.10%)
7.5M
EVAXEvaxion Biotech AS
US$ 5.26
(44.51%)
2.91M
NVNINVNI Group Ltd
US$ 2.02
(35.57%)
2.98M
NITON2OFF Inc
US$ 1.44
(23.08%)
2.15M
TRUGTruGolf Holdings Inc
US$ 0.5889
(21.42%)
2.31M
HYZNHyzon Motors Inc
US$ 0.52
(-32.64%)
163.81k
VINCVincerx Inc
US$ 0.1053
(-18.44%)
2.08M
SMLRSemier Scientific Inc
US$ 53.05
(-13.25%)
108.8k
UPXIUpexi Inc
US$ 3.71
(-11.67%)
25.73k
MCTRCTRL Group Ltd
US$ 6.00
(-11.63%)
36.67k
HPHHighest Performances Holdings Inc
US$ 0.236
(-3.36%)
12.72M
STBXStarBox Group Holdings Ltd
US$ 0.9901
(94.10%)
7.5M
HEPAHepion Pharmaceuticals Inc
US$ 0.189
(-5.50%)
6.72M
ACONAclarion Inc
US$ 0.0461
(6.71%)
6.18M
RIMEAlgorhythm Holdings Inc
US$ 0.0337
(-1.17%)
4.25M

CYCN Discussion

게시물 보기
georgie18 georgie18 2 주 전
CYCN...$3.24...🥳... https://schrts.co/BZqjIquT ...Float in 2 Million range...CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth. The Company is leveraging its legacy soluble guanylate cyclase (sGC) stimulator assets to generate near-term revenues which will be used to implement its strategic building plan without near-term dilution.

“These agreements demonstrate Cyclerion’s progress in maximizing its legacy asset value while redirecting resources toward acquiring potential new assets,” said Regina Graul, Ph.D., President and Chief Executive Officer of Cyclerion. “These newly finalized agreements, combined with our significant reduction of operating expenses, enable the focused use of our capital to support our anticipated pipeline build in the central nervous system (CNS) space. Concurrently, we plan to raise capital, as needed, to fund our product plans to create value for shareholders and patients.” Graul continued, “Cyclerion’s diligence team, comprised of committed external experts in their respective fields, is currently in advanced stages of conducting promising asset evaluations, which we believe have the potential to be the new foundation for Cyclerion.”

Cyclerion and Akebia have re-negotiated a mutually beneficial amendment to their exclusive license agreement for praliciguat, a systemic sGC stimulator. Under the new license amendment with Akebia, Cyclerion will receive $1.75 million in upfront and near-term payments. In addition, Akebia will assume responsibility for all intellectual property expenses associated with praliciguat after Q1 2025. In 2021, Akebia paid a $3.0 million upfront payment to the Company upon signing of the license agreement, and the Company is eligible to receive additional milestone cash payments of up to approximately $560 million in total potential future development, regulatory, and commercialization milestone payments for praliciguat. In exchange for a reduction in certain development milestone payments, Cyclerion is eligible to receive certain higher, tiered, sales-based royalties ranging from mid-single-digits to twenty percent.

Cyclerion has also entered into an exclusive license option agreement for its vascular sGC stimulator, olinciguat, with a separate entity, wholly controlled by CVCO Therapeutics, Inc., a clinical stage company focused on microvascular dysfunction in cardiovascular, inflammatory and metabolic disease states. Under the terms of the agreement, the potential partner has exclusive rights to evaluate olinciguat during the option period. During the option period, the grantee has assumed responsibility for all ongoing intellectual property-related expenses associated with olinciguat.

As part of its strategic initiatives, Cyclerion previously announced a definitive agreement for the sale of its CNS assets zagociguat and CY3018 to Tisento Therapeutics in May 2023 for an $8 million cash payment and a 10% equity stake in Tisento. The amended agreement for praliciguat, and if the option for olinciguat is exercised, would represent the likely final steps in the monetization of Cyclerion’s historical portfolio. Cyclerion believes it is well positioned for the next phase in its overall strategy, to bring in new CNS assets to rebuild the pipeline.
👍️0
LowFloatLopes LowFloatLopes 2 월 전
That's usually exactly what I do sometimes I'll gamble though and stay in longer like I did today :) good strategy 👍🏼
👍️ 1
Strukture Strukture 2 월 전
I just sell the top of the rips buy the dips so long as the trend stays bullish if it goes para after i sell thats ok too
👍️0
LowFloatLopes LowFloatLopes 2 월 전
Right on cue lol 
👍️0
LowFloatLopes LowFloatLopes 2 월 전
IM still holding from that past.. I'm feeling a pop 29 or 10 in the next hour
👍️0
trader59 trader59 2 월 전
Automated wash trading, brazen manipulation of the PPS. The O/S is 2.7M shares, which means that each and every share issued and outstanding has changed hands, on average, over 40 times today. Once they turn their computers off, folks will be trapped with grossly overpriced bags.
👍️0
Strukture Strukture 2 월 전
I was out at 8.20 on that push for a quick 30%
👍️0
tw0122 tw0122 2 월 전
Gave you green light alert at $4s premarket ..lol on the monthly chart all green with 3 hits the 3rd being today 
👍️0
PonkenPlonken PonkenPlonken 2 월 전
mhmm
👍️0
LowFloatLopes LowFloatLopes 2 월 전
Got a sale set at 9.70
👍️0
LowFloatLopes LowFloatLopes 2 월 전
6.45 here :)
👍️0
Strukture Strukture 2 월 전
Re loaded at 6.30 halted up back at HOD 8.40
👍️0
ecmoney ecmoney 2 월 전
Halted again $8.39

Ec
👍️0
LowFloatLopes LowFloatLopes 2 월 전
In at $4.30 out at $7.90 in 15 mins lol 
👍️0
Strukture Strukture 2 월 전
CYCN Boom
👍️0
ecmoney ecmoney 2 월 전
Halted at $6

Rc
👍️0
Invest-in-America Invest-in-America 2 월 전
CYCN: Could NOT find any PR's nor otherwise NEWS anywhere to support this??? (Just the MM machines & algos???)
👍️0
ecmoney ecmoney 2 월 전
Thinking about jumping back in around $5


Ec
👍️0
glenn1919 glenn1919 2 월 전
CYCN.....................................$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
ecmoney ecmoney 2 월 전
I’m out

Easy 300%

Ec
👍️0
tw0122 tw0122 2 월 전
$6.43 + 300% going to cash out now 
👍️0
tw0122 tw0122 2 월 전
$5.49'+ 250%
👍️0
tw0122 tw0122 2 월 전
Party over here also $5.05 + 210%
👍️0
tw0122 tw0122 2 월 전
CYCN $4.88 + 200% 
👍️0
tw0122 tw0122 2 월 전
CYCN 2.62 +92% flip out time 
👍️0
glenn1919 glenn1919 2 월 전
cycn.......................................................https://stockcharts.com/h-sc/ui?s=cycn&p=D&yr=0&mn=2&dy=12&id=p84071410134


...............................nice bounce & volume..................................................
👍️0
tw0122 tw0122 2 월 전
2.49 +'83%
👍️0
tw0122 tw0122 2 월 전
CYCN $2.26 + 70%
👍️0
glenn1919 glenn1919 2 월 전
CYCN.................................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 월 전
CYCN.................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 월 전
$2.40- $2.65 first line of resistance breaks solid $3.16 next 
👍️0
tw0122 tw0122 2 월 전
Mini pump
👍️0
Banjo50 Banjo50 6 월 전
It should be five cents. I bid five cents.
👍️0
Invest-in-America Invest-in-America 6 월 전
CYCN: Closed up by 55% today (Etrade), but no posts here for months.
👍️0
dinogreeves dinogreeves 2 년 전
CYCN with big volume could run to the teens.
👍️0
dinogreeves dinogreeves 2 년 전
Boombaska.
👍️0
dinogreeves dinogreeves 2 년 전
One heck of a run coming here fairly soon. Buy the dip and enjoy the rip. CEO paid $8.50 for shares here.
👍️0
Invest-in-America Invest-in-America 2 년 전
CYCN: Hey, & "Little Debbie" is still alive and well!! (See her below!! However, NOT quite as 'cute' as she used to be, though.)



👍️0
subslover subslover 2 년 전
LMAO. You're still partying from Friday night. I know a few peps that need your stuff! :)
👍️0
Invest-in-America Invest-in-America 2 년 전
CYCN: Get ready to PARTY!!! My glorious CYCN HomeBoys, HomeGirls, & straight-up GangBangers!!! I gots the party MUSIC for ya-all, below!!! Who's gonna bring the REFRESHMENTS!!!??? (Hey, Admiral S-L, how about some disruptive, brand-new, very tasty, "Little-Debbie-Cannabis-Infused-Strawberry-Snack-Cakes", Dude!!!???)

👍️0
subslover subslover 2 년 전
Cyclerion's zagociguat gets FDA orphan drug status
👍️0
subslover subslover 2 년 전
Cyclerion's zagociguat gets FDA orphan drug status
👍️0
NYCJR NYCJR 2 년 전
funny its a lot more than that now , close to 12x your call, lol
👍️0
willlbone willlbone 2 년 전
45% layoffs. Bid 25 cents.
👍️0
Banjo50 Banjo50 2 년 전
I think it should be 5 cents. I bid 5 cents EACH for 100 shares. Five cents is fair.
👍️0
kzivann kzivann 2 년 전
Bid for some.

CYCN
👍️0
willlbone willlbone 3 년 전
Bounce back and close the gap.
👍️0
Banjo50 Banjo50 3 년 전
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
Banjo50 Banjo50 3 년 전
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
ClayTrader ClayTrader 4 년 전
* * $CYCN Video Chart 06-08-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

최근 히스토리

Delayed Upgrade Clock